This company listing is no longer active
Resumen de acción ICCM
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de IceCure Medical Ltd
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₪4.25 |
| 52 Week High | ₪14.97 |
| 52 Week Low | ₪3.34 |
| Beta | 1.6 |
| 1 Month Change | 3.71% |
| 3 Month Change | -11.91% |
| 1 Year Change | -27.13% |
| 3 Year Change | -16.00% |
| 5 Year Change | -33.86% |
| Change since IPO | -99.33% |
Noticias y actualizaciones recientes
Recent updates
Will IceCure Medical (TLV:ICCM) Spend Its Cash Wisely?
Jul 13
Here's Why We're Watching IceCure Medical's (TLV:ICCM) Cash Burn Situation
Mar 29Are Investors Undervaluing IceCure Medical Ltd (TLV:ICCM) By 29%?
Sep 06Is IceCure Medical Ltd (TLV:ICCM) Potentially Undervalued?
Mar 03Is IceCure Medical (TLV:ICCM) In A Good Position To Deliver On Growth Plans?
Dec 13Rentabilidad de los accionistas
| ICCM | IL Medical Equipment | Mercado IL | |
|---|---|---|---|
| 7D | -3.6% | -1.3% | 0.8% |
| 1Y | -27.1% | 5.2% | 8.6% |
Rentabilidad vs. Industria: ICCM exceeded the IL Medical Equipment industry which returned -45.2% over the past year.
Rentabilidad vs. Mercado: ICCM underperformed the IL Market which returned -12.4% over the past year.
Volatilidad de los precios
| ICCM volatility | |
|---|---|
| ICCM Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.1% |
| 10% least volatile stocks in IL Market | 3.1% |
Precio estable de las acciones: ICCM has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: ICCM's weekly volatility has decreased from 43% to 5% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2006 | 69 | Eyal Shamir | icecure-medical.com |
Resumen de fundamentos de IceCure Medical Ltd
| Estadísticas fundamentales de ICCM | |
|---|---|
| Capitalización bursátil | ₪194.08m |
| Beneficios(TTM) | -₪59.62m |
| Ingresos (TTM) | ₪11.15m |
17.4x
Ratio precio-ventas (PS)-3.3x
Ratio precio-beneficio (PE)¿Está ICCM sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ICCM | |
|---|---|
| Ingresos | US$3.05m |
| Coste de los ingresos | US$1.72m |
| Beneficio bruto | US$1.33m |
| Otros gastos | US$17.63m |
| Beneficios | -US$16.30m |
Últimos beneficios comunicados
Mar 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.36 |
| Margen bruto | 43.67% |
| Margen de beneficio neto | -534.74% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado ICCM a largo plazo?
Ver rendimiento histórico y comparativa